Article
Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations.
Antiviral therapy - 1 Apr 2004
Bartholomeusz Angeline, Tehan Benjamin G, Chalmers David K
Abstract excerpt
The antiviral treatment of chronic hepatitis B is limited by the selection of antiviral resistance mutations. Primary resistance to lamivudine occurs at rtM2041/V in the C Domain of the polymerase. Recently, resistance to adefovir has also been described in the D Domain at rtN236T. The treatment of patients with resistant virus without complete suppression can lead to the further selection of compensatory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
